Search results

Page title matches

• Trastuzumab
  ...t cancer]].<ref name="pmid17611206">{{cite journal| author=Hudis CA| title=Trastuzumab--mechanism of action and use in clinical practice. | journal=N Engl J Med |
  707 bytes (88 words) - 11:35, 23 March 2010
• Trastuzumab/Definition
  131 bytes (15 words) - 07:56, 5 February 2009
• Trastuzumab/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Trastuzumab]]. Needs checking by a human.
  457 bytes (58 words) - 21:04, 11 January 2010

Page text matches

• Trastuzumab
  ...t cancer]].<ref name="pmid17611206">{{cite journal| author=Hudis CA| title=Trastuzumab--mechanism of action and use in clinical practice. | journal=N Engl J Med |
  707 bytes (88 words) - 11:35, 23 March 2010
• Trastuzumab/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Trastuzumab]]. Needs checking by a human.
  457 bytes (58 words) - 21:04, 11 January 2010
• Monoclonal antibody/Related Articles
  {{r|Trastuzumab}}
  640 bytes (83 words) - 18:38, 11 January 2010
• ErbB-2 receptor
  ...t cancer]].<ref name="pmid17611206">{{cite journal| author=Hudis CA| title=Trastuzumab--mechanism of action and use in clinical practice. | journal=N Engl J Med |
  2 KB (308 words) - 06:03, 16 July 2010
• Antineoplastic agent
  ...that lengthens remission time in metastatic [[breast cancer]]."<ref>{{MeSH|Trastuzumab [Substance Name]}}</ref>
  10 KB (1,356 words) - 06:07, 5 April 2024
• Antineoplastic agent/Related Articles
  {{r|Trastuzumab}}"HER2 (Entrez protein) antibody that lengthens remission time in metastati
  4 KB (467 words) - 00:17, 6 February 2009
• 90Y-Ibritumomab Tiuxetan
  13. Costantini, D, et. al. 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger E
  11 KB (1,563 words) - 03:38, 7 October 2013
• Breast cancer
  ...mab]] (Herceptin), a [[monoclonal antibody]] that targets this protein. [[Trastuzumab]] may be used both in the postsurgical setting (so-called "[[adjuvant]]" th ...eir growth.<ref name="pmid17611206">{{cite journal| author=Hudis CA| title=Trastuzumab--mechanism of action and use in clinical practice. | journal=N Engl J Med |
  101 KB (14,716 words) - 09:04, 5 April 2024